University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Treatment Preference and Patient Centered Prostate Cancer Care

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Other: Preference Based Decision Aid

First Posted Date: 2014-01-10

Last Posted Date: 2020-08-04

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 743

Registration Number: NCT02032550

Locations: 🇺🇸
Philadelphia Veteran's Affairs Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia

Phase 2

Completed

Conditions: Patients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment Options

Interventions: Biological: CART-19

First Posted Date: 2014-01-09

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 42

Registration Number: NCT02030847

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas

Phase 2

Completed

Conditions: Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas

Interventions: Biological: CART-19

First Posted Date: 2014-01-09

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 63

Registration Number: NCT02030834

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Motherhood and Microbiome

Completed

Conditions: Preterm Birth

First Posted Date: 2014-01-08

Last Posted Date: 2017-09-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2000

Registration Number: NCT02030106

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Way to Be Active IV (Framing vs Incentives)

Not Applicable

Completed

Conditions: Sedentary Lifestyle

Interventions: Behavioral: Teams
Behavioral: Financial incentives
Behavioral: Daily Feedback
Behavioral: Framing of feedback

First Posted Date: 2014-01-08

Last Posted Date: 2017-12-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 288

Registration Number: NCT02030080

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Way to Be Active V (Framing vs. Forgiveness)

Not Applicable

Completed

Conditions: Sedentary Lifestyle

Interventions: Behavioral: Forgiveness
Behavioral: Feedback compared to 75th percentile
Behavioral: Daily Feedback
Behavioral: Financial Incentive

First Posted Date: 2014-01-08

Last Posted Date: 2017-03-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 288

Registration Number: NCT02030132

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Way to Be Active III (Framing Incentives)

Not Applicable

Completed

Conditions: Sedentary Lifestyle

Interventions: Behavioral: Financial Incentives
Behavioral: Daily feedback

First Posted Date: 2014-01-08

Last Posted Date: 2017-12-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 281

Registration Number: NCT02030119

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Feeding Progression in Preterm Infants

Not Applicable

Completed

Conditions: Infant, Premature, Diseases
Feeding Patterns
Feeding Behavior

Interventions: Other: q6 hour oral feeding schedule
Other: q3 hour oral feeding schedule

First Posted Date: 2014-01-06

Last Posted Date: 2015-12-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 55

Registration Number: NCT02027688

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

Sorafenib for Hepatopulmonary Syndrome

Phase 2

Terminated

Conditions: Hepatopulmonary Syndrome

Interventions: Drug: Placebo
Drug: Sorafenib

First Posted Date: 2013-12-27

Last Posted Date: 2019-04-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 28

Registration Number: NCT02021929

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸
University of Texas Health Science Center at Houston Medical School, Houston, Texas, United States
🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States

and more 4 locations

Second Study to Assess Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial Fibrillation

Not Applicable

Terminated

Conditions: Atrial Fibrillation

Interventions: Other: Pulmonary Vein Isolation procedure

First Posted Date: 2013-12-24

Last Posted Date: 2016-08-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 56

Registration Number: NCT02019238

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy